EFFICACY AND SAFETY OF UPADACITINIB IN TNFI INADEQUATE RESPONDERS WITH RHEUMATOID ARTHRITIS FROM THREE PHASE 3 CLINICAL TRIALS

被引：0
|
作者：
Fleischmann, Roy [1 ]
Bessette, Louis [2 ]
Hall, Stephen [3 ,4 ]
Sparks, Jeffrey [5 ]
Jain, Manish [6 ]
Kakehasi, Adriana [7 ]
Song, Yanna [8 ]
Meerwein, Sebastian [8 ]
DeMasi, Ryan [8 ]
Suboticki, Jessica [8 ]
Rubbert-Roth, Andrea [9 ]
机构：
[1] Metroplex Clin Res Ctr, Rheumatol, Dallas, TX USA
[2] Laval Univ, Div Rheumatol, Dept Med, Quebec City, PQ, Canada
[3] Monash Univ, Rheumatol, Melbourne, Australia
[4] Emeritus Res, Melbourne, Australia
[5] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA USA
[6] Great Lakes Clin Trials, Rheumatol, Chicago, IL USA
[7] Univ Fed Minas Gerais, Hosp Clin, Rheumatol, Belo Horizonte, Brazil
[8] AbbVie Inc, Immunol, Chicago, IL USA
[9] Cantonal Clin St Gallen, Div Rheumatol, St Gallen, Switzerland
来源：
RHEUMATOLOGY | 2023年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P135
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGICS: 3-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY
    Mease, P. J.
    Setty, A.
    Papp, K.
    Van den Bosch, F.
    Tsuji, S.
    Keiserman, M.
    Carter, K.
    Mccaskill, R.
    Mcdearmon-Blondell, E.
    Wung, P.
    Tillett, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1136 - 1137
  • [32] Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis: analysis of two Phase 3 randomised clinical trials
    Tanaka, Yoshiya
    Takahashi, Toshiya
    Sumi, Mariko
    Hagino, Owen
    Van Hoogstraten, Hubert
    Xu, Christine
    Kato, Naoto
    Kameda, Hideto
    MODERN RHEUMATOLOGY, 2022, 32 (04) : 686 - 695
  • [33] Safety of tocilizumab in patients with rheumatoid arthritis: Pooled analysis of five phase 3 clinical trials
    Smolen, Josef S.
    Beaulieu, Andre D.
    Dikranian, Ara
    Fenton, Ira
    Fisheleva, Elena
    Alecock, Emma
    Emery, Paul
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S784 - S784
  • [34] Efficacy and Safety of Sarilumab in Combination with Csdmards in Patients with Active Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant of Anti-TNF-I± Therapy: Results from a Phase 3 Study
    Fleischmann, Roy
    Castelar-Pinheiro, Geraldo
    Brzezicki, Jan
    Hrycaj, Pawel
    Lin, Yong
    van adelsberg, Janet
    Graham, Neil
    van Hoogstraten, Hubert
    Bauer, Deborah
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [35] The Association between Patient Reported Outcomes and Clinical Measures Among Rheumatoid Arthritis Patients: Analyses Using Phase 3 Clinical Trials of Upadacitinib
    Strand, Vibeke
    Damjanov, Nemanja
    Scoville, Craig
    Tundia, Namita
    Camp, Heidi S.
    Chen, Kun
    Suboticki, Jessica
    van Vollenhoven, Ronald
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [36] Exposure-Response Analyses of Upadacitinib Efficacy in Phase II Trials in Rheumatoid Arthritis and Basis for Phase III Dose Selection
    Mohamed, Mohamed-Eslam F.
    Kluender, Ben
    Camp, Heidi S.
    Othman, Ahmed A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (06) : 1319 - 1327
  • [37] THE ASSOCIATION BETWEEN PATIENT REPORTED OUTCOMES AND CLINICAL MEASURES AMONG RHEUMATOID ARTHRITIS PATIENTS: ANALYSES USING PHASE 3 CLINICAL TRIALS OF UPADACITINIB
    Strand, Vibeke
    Damjanov, Nemanja
    Scoville, Craig
    Tundia, Namita
    Camp, Heidi
    Chen, Kun
    Suboticki, Jessica L.
    van Vollenhoven, Ronald
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S54 - S54
  • [38] Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders
    Amano, Koichi
    Matsubara, Tsukasa
    Tanaka, Takaaki
    Inoue, Hiroshi
    Iwahashi, Mitsuhiro
    Kanamono, Toshihisa
    Nakano, Teruaki
    Uchimura, Shoichi
    Izumihara, Tomomaro
    Yamazaki, Akira
    Karyekar, Chetan S.
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2015, 25 (05) : 665 - 671
  • [39] EFFECTS OF SMOKING ON BARICITINIB EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED ANALYSIS FROM TWO PHASE 3 CLINICAL TRIALS
    Curtis, J.
    Emery, P.
    Burmester, G.
    Arora, V.
    Alam, J.
    Muram, D.
    Klareskog, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 244 - 244
  • [40] Safety of Glucocorticoids in Rheumatoid Arthritis: Evidence from Recent Clinical Trials
    Santiago, Tania
    da Silva, Jose Antnio P.
    NEUROIMMUNOMODULATION, 2015, 22 (1-2) : 57 - 65
12345